Stock Taper 
Alignment Healthcare, Inc. is a California-based, tech-enabled Medicare Advantage provider offering personalized health plans and services to seniors in California, North Carolina, and Nevada since 2013.
Alignment Healthcare offers 2026 Medicare Advantage plans, including HMOs and SNPs, featuring 24/7 ACCESS Concierge support and benefits like dental, meal, and transportation services for seniors.
Alignment Healthcare announced its third-quarter 2025 financial results on October 30th, reporting earnings per share (EPS) of $0.02, significantly beating analysts' consensus estimates of a $0.01 loss. The company also surpassed revenue expectations and raised its full-year guidance. This strong performance prompted a series of positive actions from financial analysts, including rating upgrades and price target increases from major firms like JPMorgan, Goldman Sachs, and Piper Sandler in the following weeks, which fueled a significant stock price rally into the end of the year.
In a significant strategic move for 2025, Alignment Healthcare launched a series of new Medicare Advantage plans specifically targeting vulnerable and chronically ill seniors. This initiative includes new Dual-Eligible Special Needs Plans (D-SNPs) in Texas and Chronic Condition Special Needs Plans (C-SNPs) in California for members with specific lung or mental health conditions, signaling a deeper push into specialized care management.
SAN FRANCISCO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Hagens Berman is updating its ongoing investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) on behalf of investors following a nearly 20% stock collapse on Tuesday following management's disclosures at an analyst conference. Investors who have suffered significant losses are encouraged to submit their losses now.
ORANGE, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage (MA) plan from Alignment Health, today announced its 2027 Medicare Advantage portfolio.
Overall rating: B
| PEER | PRICE | |
|---|---|---|
 OSCR | $30.94 | COMPARE |
 GRAL | $143.26 | COMPARE |
 MIRM | $82.93 | COMPARE |
 ICUI | $159.38 | COMPARE |
 NVST | $23.46 | COMPARE |
 DYN | $15.20 | COMPARE |
 PRVA | $20.30 | COMPARE |
 RARE | $15.22 | COMPARE |
